Author

Hiromitsu Tsuchihashi

Institution: Osaka Medical and Pharmaceutical University

Observed institution: Osaka Medical and Pharmaceutical University

OpenAlex ID: A5017811366

Which is better for predicting pelvic lymph node metastases in patients with cervical cancer

2018 · Tomohito Tanaka, Shun Sasaki, et al. · Medicine · 16

Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial Cancer

2023 · Shinichi Terada, Tomohito Tanaka, et al. · Journal of Clinical Medicine · 14

Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma

2022 · Hiroshi Maruoka, Tomohito Tanaka, et al. · International Journal of Molecular Sciences · 10

Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy

2024 · Tomohito Tanaka, Ruri Nishie, et al. · Journal of Clinical Medicine · 2

Creation and Validation of Patient-Derived Cancer Model Using Peritoneal and Pleural Effusion in Patients with Advanced Ovarian Cancer: An Early Experience

2024 · Ruri Nishie, Tomohito Tanaka, et al. · Journal of Clinical Medicine · 1

Consistency between Primary Uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models

2024 · Shoko Ueda, Tomohito Tanaka, et al. · International Journal of Molecular Sciences · 1

Creation and validation of a patient-derived cancer model using peritoneal and pleural effusion samples from patients with ovarian cancer

2023 · Ruri Nishie, Tomohito Tanaka, et al. · Research Square

Works count: 7

Citation count: 44

H-index: 3

I10-index: 3